TTrialPathMatch Me to Trials
← Back to trials
RecruitingPregnant IndividualsObesity & OverweightGestational Weight Gain

Gestational Response, Outcomes, and Weight After GLP-1 Use

Eligible age

18–45 yrs

Accepts

Women

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Sponsor: University of Kansas Medical Center

You may qualify if…

  • Adult women
  • Less than or equal to 20 weeks gestation at first visit
  • English speaking

You may not qualify if…

  • \<18 years at time of initial visit
  • Type 2 diabetes
  • History of bariatric surgery
  • Multiple gestation
  • Cannot consent for themselves
  • Cannot read and speak English
  • Incarcerated

Where it's recruiting

Kansas

Kansas City

Source: ClinicalTrials.gov · NCT07743567 · last updated 2026-08-04

Gestational Response, Outcomes, and Weight After GLP-1 Use · TrialPath